Home / Atazanavir and Cobicistat / United States
US ATC J05AR15 · updated 2 Nov 2026
Atazanavir and Cobicistat shortage in United States
Is there an Atazanavir and Cobicistat shortage in United States?
Yes. As of 2 Nov 2026, 1 Atazanavir and Cobicistat product is reported short in United States, the first since 3 Nov 2025. No return date has been given. Main reason: not stated.
Not reported short in any other country we track. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Evotaz, Tablet, 300 mg; 150 mg (NDC 0003-3641-11) discontinuation | Bristol Myers Squibb Co. | 3 Nov 2025 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).